Article(id=1330225004379222970, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330224864159445597, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.01.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1625587200000, receivedDateStr=2021-07-07, revisedDate=1640102400000, revisedDateStr=2021-12-22, acceptedDate=null, acceptedDateStr=null, onlineDate=1795079955428, onlineDateStr=2026-11-19, pubDate=1641744000000, pubDateStr=2022-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795079955428, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795079955428, creator=13701087609, updateTime=1795079955428, updator=13701087609, issue=Issue{id=1330224864159445597, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='1', pageStart='1', pageEnd='104', issueExtLink='null', onlineDate='null', pubDate='1641744000000', pubDateStr='2022-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795079921998, creator='13701087609', updateTime=1795084657767, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244727875678840, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330224864159445597, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244727875678841, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330224864159445597, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=87, endPage=90, ext={EN=ArticleExt(id=1330225004601521083, articleId=1330225004379222970, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Clinical research progress of interleukin-15 in tumor immunotherapy, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Interleukin-15 (IL-15) is a pleiotropic cytokine, which has a unique effect on natural killer cells (NK cells) and memory T cells, suggesting that it has tumor immunotherapy potential. With the rapid development of tumor immunotherapy and related drug research, clinical research related to IL-15 is being carried out in an orderly manner around the world. This article reviewed the current status and progress of clinical research on tumor immunotherapy of IL-15.

, authors=Ziwen DING1, Lu WANG1, Yan REN1, Yan ZHENG2, Yuan LI2, Jingyan ZHANG2, *, Na NI1, 2, *, authorsList=Ziwen DING, Lu WANG, Yan REN, Yan ZHENG, Yuan LI, Jingyan ZHANG, Na NI, authorCompany=null, correspAuthors=Jingyan ZHANG, Na NI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225004840596412, articleId=1330225004379222970, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=白介素15在肿瘤免疫治疗中的临床研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

白介素15(interleukin-15,IL-15)是一种多效性细胞因子,对自然杀伤细胞和记忆T细胞有其独特作用,提示具有肿瘤免疫治疗的潜力。随着肿瘤免疫治疗的发展及相关药物的研发应用,IL-15相关的临床研究正在全世界范围内有序开展。该文围绕IL-15的肿瘤免疫治疗,现就临床研究方向的研究现状与进展作一综述。

, authors=丁子文1, 汪璐1, 任燕1, 郑岩2, 李渊2, 张婧妍2, *, 倪娜1, 2, *, authorsList=丁子文, 汪璐, 任燕, 郑岩, 李渊, 张婧妍, 倪娜, authorCompany=null, correspAuthors=张婧妍, 倪娜, authorNote=

丁子文,硕士研究生,研究方向:抗肿瘤药的临床药学研究。

, correspAuthorsNote=
张婧妍,助理研究员,研究方向:抗肿瘤药的临床药学研究。
倪娜,副研究员,研究方向:抗肿瘤药的临床药学研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=zqBGCN6vuYjI0t1dhVY8jg==, magXml=iP10g6YNzuby4G8aOFr9pg==, pdfUrl=null, pdf=B+IwoUjGF/z4Sgyn55OJyQ==, pdfFileSize=1675924, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=g4/U/wow0TfM0KYVmwvhRQ==, mapNumber=null, fund=null)}, authors=[Author(id=1330225005188723652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225005255832518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005188723652, language=EN, stringName=Ziwen DING, firstName=Ziwen, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225005322941383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005188723652, language=CN, stringName=丁子文, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio={"content":"

丁子文,硕士研究生,研究方向:抗肿瘤药的临床药学研究。

"}, bioImg=null, bioContent=

丁子文,硕士研究生,研究方向:抗肿瘤药的临床药学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005029340093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=1., ext=[AuthorCompanyExt(id=1330225005041923006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225005050311615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225005385855945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225005448770507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005385855945, language=EN, stringName=Lu WANG, firstName=Lu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225005511685068, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005385855945, language=CN, stringName=汪璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005029340093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=1., ext=[AuthorCompanyExt(id=1330225005041923006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225005050311615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225005578793934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225005658485712, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005578793934, language=EN, stringName=Yan REN, firstName=Yan, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225005717205969, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005578793934, language=CN, stringName=任燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005029340093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=1., ext=[AuthorCompanyExt(id=1330225005041923006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225005050311615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225005792703443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225005855618005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005792703443, language=EN, stringName=Yan ZHENG, firstName=Yan, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225005922726870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005792703443, language=CN, stringName=郑岩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005113226176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=2., ext=[AuthorCompanyExt(id=1330225005125809089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225005130003394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225005989835736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225006056944602, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005989835736, language=EN, stringName=Yuan LI, firstName=Yuan, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225006178579419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005989835736, language=CN, stringName=李渊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005113226176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=2., ext=[AuthorCompanyExt(id=1330225005125809089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225005130003394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225006245688285, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225006316991455, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225006245688285, language=EN, stringName=Jingyan ZHANG, firstName=Jingyan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225006384100320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225006245688285, language=CN, stringName=张婧妍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005113226176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=2., ext=[AuthorCompanyExt(id=1330225005125809089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225005130003394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225006455403490, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=6, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225006526706661, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225006455403490, language=EN, stringName=Na NI, firstName=Na, middleName=null, lastName=NI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225008120542182, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225006455403490, language=CN, stringName=倪娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437
2.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005029340093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=1., ext=[AuthorCompanyExt(id=1330225005041923006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225005050311615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)]), AuthorCompany(id=1330225005113226176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=2., ext=[AuthorCompanyExt(id=1330225005125809089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225005130003394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海瀛科隆医药开发有限公司,上海 200437)])])], keywords=[Keyword(id=1330225008229594087, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, language=EN, orderNo=1, keyword=interleukin-15), Keyword(id=1330225008300897256, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, language=EN, orderNo=2, keyword=tumor immunotherapy), Keyword(id=1330225008363811817, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, language=EN, orderNo=3, keyword=clinical research), Keyword(id=1330225008430920682, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, language=CN, orderNo=1, keyword=白介素15), Keyword(id=1330225008493835243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, language=CN, orderNo=2, keyword=肿瘤免疫治疗), Keyword(id=1330225008565138412, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, language=CN, orderNo=3, keyword=临床研究)], refs=[Reference(id=1330225008649024493, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Bergamaschi C, Jalah R, Kulkarni V, et al. Secretion and biological activity of short signal peptide IL-15 is chaperoned by IL-15 receptor alpha in vivo[J]. J Immunol, 2009, 183(5): 3064-3072., articleTitle=null, refAbstract=null), Reference(id=1330225008711939054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=邢续扬, 王孝春, 何伟. 肿瘤免疫治疗及其药物研发进展[J]. 中国药科大学学报, 2021, 52(1): 10-19., articleTitle=null, refAbstract=null), Reference(id=1330225008770659311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design[J]. Nat Rev Immunol, 2006, 6(8): 595-601., articleTitle=null, refAbstract=null), Reference(id=1330225008837768176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Read KA, Powell MD, McDonald PW, et al. IL-2, IL-7, and IL-15: Multistage regulators of CD4(+) T helper cell differentiation[J]. Exp Hematol, 2016, 44(9): 799-808., articleTitle=null, refAbstract=null), Reference(id=1330225008913265649, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Klebanoff CA, Finkelstein SE, Surman DR, et al. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells[J]. Proc Natl Acad Sci U S A, 2004, 101(7): 1969-1974., articleTitle=null, refAbstract=null), Reference(id=1330225008976180210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Teague RM, Sather BD, Sacks JA, et al. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors[J]. Nat Med, 2006, 12(3): 335-341., articleTitle=null, refAbstract=null), Reference(id=1330225009039094772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Sneller MC, Kopp WC, Engelke KJ, et al. IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood[J]. Blood, 2011, 118(26): 6845-6848., articleTitle=null, refAbstract=null), Reference(id=1330225009110397942, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Waldmann TA, Lugli E, Roederer M, et al. Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques[J]. Blood, 2011, 117(18): 4787-4795., articleTitle=null, refAbstract=null), Reference(id=1330225009181701111, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Lugli E, Goldman CK, Perera LP, et al. Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates[J]. Blood, 2010, 116(17): 3238-3248., articleTitle=null, refAbstract=null), Reference(id=1330225009253004280, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Conlon KC, Lugli E, Welles HC, et al. Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer[J]. J Clin Oncol, 2015, 33(1): 74-82., articleTitle=null, refAbstract=null), Reference(id=1330225009341084665, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Conlon KC, Potter EL, Pittaluga S, et al. IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion[J]. Clin Cancer Res, 2019, 25(16): 4945-4954., articleTitle=null, refAbstract=null), Reference(id=1330225009416582138, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Miller JS, Morishima C, McNeel DG, et al. A first-in-human phase I study of subcutaneous outpatient recombinant human IL15 (rhIL15) in adults with advanced solid tumors[J]. Clin Cancer Res, 2018, 24(7): 1525-1535., articleTitle=null, refAbstract=null), Reference(id=1330225009492079611, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Bessard A, Solé V, Bouchaud G, et al. High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor alpha fusion protein, in metastatic melanoma and colorectal cancer[J]. Mol Cancer Ther, 2009, 8(9): 2736-2745., articleTitle=null, refAbstract=null), Reference(id=1330225009567577084, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Cooley S, He F, Bachanova V, et al. First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia[J]. Blood Adv, 2019, 3(13): 1970-1980., articleTitle=null, refAbstract=null), Reference(id=1330225009647268861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Drusbosky L, Nangia C, Nguyen A, et al. Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study[J]. J Immunother Cancer, 2020, 8(2): e001098., articleTitle=null, refAbstract=null), Reference(id=1330225009722766334, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Wrangle JM, Velcheti V, Patel MR, et al. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial[J]. Lancet Oncol, 2018, 19(5): 694-704., articleTitle=null, refAbstract=null), Reference(id=1330225009815041023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Miljkovic MD, Conlon KC, Albert J, et al. Phase 1 study of subcutaneous recombinant human (rh) interleukin-15 and intravenous alemtuzumab in patients with rrelapsed/refractory T-cell lymphoma[J]. Blood, 2020, 136(S1): 23-24., articleTitle=null, refAbstract=null), Reference(id=1330225009877955584, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Foltz JA, Hess BT, Bachanova V, et al. Phase I trial of N-803, an IL15 receptor agonist, with rituximab in patients with indolent non-hodgkin lymphoma[J]. Clin Cancer Res, 2021, 27(12): 3339-3350., articleTitle=null, refAbstract=null), Reference(id=1330225009945063424, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Bachanova V, Cooley S, Defor TE, et al. Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein[J]. Blood, 2014; 123(25): 3855-3863., articleTitle=null, refAbstract=null), Reference(id=1330225010024755201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=刘建萍, 龚志勇. 卡介苗膀胱灌注新进展[J]. 临床泌尿外科杂志, 2020, 35(11): 933-938., articleTitle=null, refAbstract=null), Reference(id=1330225010100252674, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Rosser CJ, Tikhonenkov S, Nix JW, et al. Safety, tolerability, and long-term clinical outcomes of an IL-15 analogue (N-803) admixed with bacillus Calmette-Guérin (BCG) for the treatment of bladder cancer[J]. Oncoimmunology. 2021, 10(1): 1912885., articleTitle=null, refAbstract=null), Reference(id=1330225010167361539, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Chamie K, Chang S, Gonzalgo ML, et al. Phase II/III clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS) patients[J]. J Clin Oncol, 2021, 39(S6): 510-510., articleTitle=null, refAbstract=null), Reference(id=1330225010238664708, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Hutmacher C, Neri D. Antibody-cytokine fusion proteins: biopharmaceuticals with immunomodulatory properties for cancer therapy[J]. Adv Drug Deliv Rev, 2019, 141: 67-91., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225005029340093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=1., ext=[AuthorCompanyExt(id=1330225005041923006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225005050311615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)]), AuthorCompany(id=1330225005113226176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=2., ext=[AuthorCompanyExt(id=1330225005125809089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225005130003394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海瀛科隆医药开发有限公司,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.01.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.01.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.01.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.01.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1641744000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
白介素15在肿瘤免疫治疗中的临床研究进展
丁子文 1 , 汪璐 1 , 任燕 1 , 郑岩 2 , 李渊 2 , 张婧妍 2, * , 倪娜 1, 2, *
世界临床药物 | 综述评论 2022,43(1): 87-90
收起
收藏切换
世界临床药物 |综述评论 2022 , 43 (1) : 87 -90
白介素15在肿瘤免疫治疗中的临床研究进展
全屏
[Author(id=1330225005188723652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225005255832518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005188723652, language=EN, stringName=Ziwen DING, firstName=Ziwen, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225005322941383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005188723652, language=CN, stringName=丁子文, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio={"content":"

丁子文,硕士研究生,研究方向:抗肿瘤药的临床药学研究。

"}, bioImg=null, bioContent=

丁子文,硕士研究生,研究方向:抗肿瘤药的临床药学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005029340093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=1., ext=[AuthorCompanyExt(id=1330225005041923006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225005050311615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225005385855945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225005448770507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005385855945, language=EN, stringName=Lu WANG, firstName=Lu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225005511685068, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005385855945, language=CN, stringName=汪璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005029340093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=1., ext=[AuthorCompanyExt(id=1330225005041923006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225005050311615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225005578793934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225005658485712, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005578793934, language=EN, stringName=Yan REN, firstName=Yan, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225005717205969, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005578793934, language=CN, stringName=任燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005029340093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=1., ext=[AuthorCompanyExt(id=1330225005041923006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225005050311615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225005792703443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225005855618005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005792703443, language=EN, stringName=Yan ZHENG, firstName=Yan, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225005922726870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005792703443, language=CN, stringName=郑岩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005113226176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=2., ext=[AuthorCompanyExt(id=1330225005125809089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225005130003394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225005989835736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225006056944602, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005989835736, language=EN, stringName=Yuan LI, firstName=Yuan, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225006178579419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225005989835736, language=CN, stringName=李渊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005113226176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=2., ext=[AuthorCompanyExt(id=1330225005125809089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225005130003394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225006245688285, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225006316991455, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225006245688285, language=EN, stringName=Jingyan ZHANG, firstName=Jingyan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225006384100320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225006245688285, language=CN, stringName=张婧妍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005113226176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=2., ext=[AuthorCompanyExt(id=1330225005125809089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225005130003394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225006455403490, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, orderNo=6, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225006526706661, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225006455403490, language=EN, stringName=Na NI, firstName=Na, middleName=null, lastName=NI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225008120542182, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, authorId=1330225006455403490, language=CN, stringName=倪娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院药物临床研究中心,上海 200437
2.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225005029340093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=1., ext=[AuthorCompanyExt(id=1330225005041923006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225005050311615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005029340093, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院药物临床研究中心,上海 200437)]), AuthorCompany(id=1330225005113226176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, xref=2., ext=[AuthorCompanyExt(id=1330225005125809089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225005130003394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225004379222970, companyId=1330225005113226176, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海瀛科隆医药开发有限公司,上海 200437)])])]
丁子文1, 汪璐1, 任燕1, 郑岩2, 李渊2, 张婧妍2, *, 倪娜1, 2, *
作者信息
  • 1.中国医药工业研究总院药物临床研究中心,上海 200437
  • 2.上海瀛科隆医药开发有限公司,上海 200437
通讯作者:
张婧妍,助理研究员,研究方向:抗肿瘤药的临床药学研究。
倪娜,副研究员,研究方向:抗肿瘤药的临床药学研究。
作者简介:

丁子文,硕士研究生,研究方向:抗肿瘤药的临床药学研究。

Clinical research progress of interleukin-15 in tumor immunotherapy
Ziwen DING1, Lu WANG1, Yan REN1, Yan ZHENG2, Yuan LI2, Jingyan ZHANG2, *, Na NI1, 2, *
Affiliations
  • 1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
出版时间: 2022-01-10 doi: 10.13683/j.wph.2022.01.016
文章导航
收藏切换

白介素15(interleukin-15,IL-15)是一种多效性细胞因子,对自然杀伤细胞和记忆T细胞有其独特作用,提示具有肿瘤免疫治疗的潜力。随着肿瘤免疫治疗的发展及相关药物的研发应用,IL-15相关的临床研究正在全世界范围内有序开展。该文围绕IL-15的肿瘤免疫治疗,现就临床研究方向的研究现状与进展作一综述。

白介素15  /  肿瘤免疫治疗  /  临床研究

Interleukin-15 (IL-15) is a pleiotropic cytokine, which has a unique effect on natural killer cells (NK cells) and memory T cells, suggesting that it has tumor immunotherapy potential. With the rapid development of tumor immunotherapy and related drug research, clinical research related to IL-15 is being carried out in an orderly manner around the world. This article reviewed the current status and progress of clinical research on tumor immunotherapy of IL-15.

interleukin-15  /  tumor immunotherapy  /  clinical research
丁子文, 汪璐, 任燕, 郑岩, 李渊, 张婧妍, 倪娜. 白介素15在肿瘤免疫治疗中的临床研究进展. 世界临床药物, 2022 , 43 (1) : 87 -90 . DOI: 10.13683/j.wph.2022.01.016
Ziwen DING, Lu WANG, Yan REN, Yan ZHENG, Yuan LI, Jingyan ZHANG, Na NI. Clinical research progress of interleukin-15 in tumor immunotherapy[J]. World Clinical Drug, 2022 , 43 (1) : 87 -90 . DOI: 10.13683/j.wph.2022.01.016

参考文献 引证文献
排序方式:
[1]
Bergamaschi C, Jalah R, Kulkarni V, et al. Secretion and biological activity of short signal peptide IL-15 is chaperoned by IL-15 receptor alpha in vivo[J]. J Immunol, 2009, 183(5): 3064-3072.
[2]
邢续扬, 王孝春, 何伟. 肿瘤免疫治疗及其药物研发进展[J]. 中国药科大学学报, 2021, 52(1): 10-19.
[3]
Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design[J]. Nat Rev Immunol, 2006, 6(8): 595-601.
[4]
Read KA, Powell MD, McDonald PW, et al. IL-2, IL-7, and IL-15: Multistage regulators of CD4(+) T helper cell differentiation[J]. Exp Hematol, 2016, 44(9): 799-808.
[5]
Klebanoff CA, Finkelstein SE, Surman DR, et al. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells[J]. Proc Natl Acad Sci U S A, 2004, 101(7): 1969-1974.
[6]
Teague RM, Sather BD, Sacks JA, et al. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors[J]. Nat Med, 2006, 12(3): 335-341.
[7]
Sneller MC, Kopp WC, Engelke KJ, et al. IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood[J]. Blood, 2011, 118(26): 6845-6848.
[8]
Waldmann TA, Lugli E, Roederer M, et al. Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques[J]. Blood, 2011, 117(18): 4787-4795.
[9]
Lugli E, Goldman CK, Perera LP, et al. Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates[J]. Blood, 2010, 116(17): 3238-3248.
[10]
Conlon KC, Lugli E, Welles HC, et al. Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer[J]. J Clin Oncol, 2015, 33(1): 74-82.
[11]
Conlon KC, Potter EL, Pittaluga S, et al. IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion[J]. Clin Cancer Res, 2019, 25(16): 4945-4954.
[12]
Miller JS, Morishima C, McNeel DG, et al. A first-in-human phase I study of subcutaneous outpatient recombinant human IL15 (rhIL15) in adults with advanced solid tumors[J]. Clin Cancer Res, 2018, 24(7): 1525-1535.
[13]
Bessard A, Solé V, Bouchaud G, et al. High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor alpha fusion protein, in metastatic melanoma and colorectal cancer[J]. Mol Cancer Ther, 2009, 8(9): 2736-2745.
[14]
Cooley S, He F, Bachanova V, et al. First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia[J]. Blood Adv, 2019, 3(13): 1970-1980.
[15]
Drusbosky L, Nangia C, Nguyen A, et al. Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study[J]. J Immunother Cancer, 2020, 8(2): e001098.
[16]
Wrangle JM, Velcheti V, Patel MR, et al. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial[J]. Lancet Oncol, 2018, 19(5): 694-704.
[17]
Miljkovic MD, Conlon KC, Albert J, et al. Phase 1 study of subcutaneous recombinant human (rh) interleukin-15 and intravenous alemtuzumab in patients with rrelapsed/refractory T-cell lymphoma[J]. Blood, 2020, 136(S1): 23-24.
[18]
Foltz JA, Hess BT, Bachanova V, et al. Phase I trial of N-803, an IL15 receptor agonist, with rituximab in patients with indolent non-hodgkin lymphoma[J]. Clin Cancer Res, 2021, 27(12): 3339-3350.
[19]
Bachanova V, Cooley S, Defor TE, et al. Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein[J]. Blood, 2014; 123(25): 3855-3863.
[20]
刘建萍, 龚志勇. 卡介苗膀胱灌注新进展[J]. 临床泌尿外科杂志, 2020, 35(11): 933-938.
[21]
Rosser CJ, Tikhonenkov S, Nix JW, et al. Safety, tolerability, and long-term clinical outcomes of an IL-15 analogue (N-803) admixed with bacillus Calmette-Guérin (BCG) for the treatment of bladder cancer[J]. Oncoimmunology. 2021, 10(1): 1912885.
[22]
Chamie K, Chang S, Gonzalgo ML, et al. Phase II/III clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS) patients[J]. J Clin Oncol, 2021, 39(S6): 510-510.
[23]
Hutmacher C, Neri D. Antibody-cytokine fusion proteins: biopharmaceuticals with immunomodulatory properties for cancer therapy[J]. Adv Drug Deliv Rev, 2019, 141: 67-91.
2022年第43卷第1期
11
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.01.016
  • 接收时间:2021-07-07
  • 首发时间:2026-11-19
  • 出版时间:2022-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-07-07
  • 修回日期:2021-12-22
基金
作者信息
    1.中国医药工业研究总院药物临床研究中心,上海 200437
    2.上海瀛科隆医药开发有限公司,上海 200437

通讯作者:

张婧妍,助理研究员,研究方向:抗肿瘤药的临床药学研究。
倪娜,副研究员,研究方向:抗肿瘤药的临床药学研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.01.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏